UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14C
Information Statement Pursuant to Section 14(c) of the
Securities Exchange Act of 1934
Check the appropriate box:
[_] Preliminary Information Statement
[_] Confidential, for Use of the Commission Only (as permitted by
Rule 14c-5(d)(2))
[X ] Definitive Information Statement
AS CAPITAL, INC.
(Name of Registrant as Specified In Its Charter)
Payment of Filing Fee (Check the appropriate box)
[X] No fee required.
[_] Fee computed on table below per Exchange Act Rules 14c-5(g) and
0-11.
1) |
Title of each
class of securities to which transaction applies: |
2) |
Aggregate number of securities to
which transaction applies: |
3) |
Per unit price or other
underlying value of transaction computed pursuant to Exchange
Act Rule 0-11 (Set forth the amount on which the filing
fee is calculated and state how it was determined): |
4) |
Proposed maximum aggregate value
of transaction: |
5) |
Total fee paid: |
[_] Fee paid previously with preliminary materials.
[_] Check box if any part of the fee is offset as provided by
Exchange Act Rule 0-11(a)(2) and identify the filing for which the
offsetting fee was paid previously. Identify the previous filing by
registration statement number, or the Form or Schedule and the date
of its filing.
1) |
Amount Previously Paid: |
2) |
Form, Schedule or Registration Statement No.: |
3) |
Filing Party: |
4) |
Date Filed: |
AS CAPITAL, INC.
3-11 Building 3, Beihuan East Road, Pinggu Town,
Pinggu District, Beijing
People's Republic of China
NOTICE OF CORPORATE ACTIONS TAKEN BY WRITTEN CONSENT
OF THE MAJORITY STOCKHOLDER WITHOUT SPECIAL MEETING OF THE
STOCKHOLDERS
Dear Stockholders:
We are writing to advise you that, on July 11, 2020, the board of
directors of AS Capital, Inc., a Nevada corporation (“ASIN,” “the
Company,” “we” or “us”), and stockholders holding a majority of the
voting rights of our common stock approved by written consent in
lieu of a special meeting the taking of all steps necessary to
effect the following actions (collectively, the “Corporate
Actions”):
|
1. |
Amend the Articles of Incorporation filed with
the Nevada Secretary of State (the “Articles of Incorporation”) to
increase the Company’s authorized capital stock from 110,000,000 to
510,000,000 shares of its capital stock, consisting of 500,000,000
shares of common stock, par value $0.0001, and 10,000,000 shares of
preferred stock, par value $0.0001; and |
|
2. |
Adopt
the Amended and Restated Bylaws of the Company. |
The accompanying information statement, which describes the
Corporate Actions in more detail, is being furnished to our
stockholders for informational purposes only, pursuant to Section
14(c) of the Securities Exchange Act of 1934, as amended (the
“Exchange Act”), and the rules and regulations prescribed
thereunder. The consent that we have received constitutes the only
stockholder approval required for the Corporate Actions under the
Nevada Revised Statutes, our Articles of Incorporation and Bylaws.
Accordingly, the Corporate Actions will not be submitted to the
other stockholders of the Company for a vote.
The record date for the determination of stockholders entitled to
notice of the action by written consent is July 11, 2020. Pursuant
to Rule 14c-2 under the Exchange Act, the Corporate Actions will
not be implemented until at least twenty (20) calendar days after
the mailing of this information statement to our
stockholders. This information statement will be mailed
on or about July 31, 2020, to stockholders of record on July 11,
2020. As such, we expect that the Corporate Actions will be
effective no earlier than August 11, 2020.
No action is required by you to effectuate this action. The
accompanying information statement is furnished only to inform our
stockholders of the action described above before it takes effect
in accordance with Rule 14c-2 promulgated under the Exchange
Act.
WE ARE NOT ASKING YOU FOR A PROXY AND YOU ARE REQUESTED NOT TO SEND
US A PROXY.
PLEASE NOTE THAT THE HOLDERS OF A MAJORITY OF OUR OUTSTANDING
SHARES OF COMMON STOCK HAVE VOTED TO AUTHORIZE THE CORPORATE
ACTIONS. THE NUMBER OF VOTES RECEIVED IS SUFFICIENT TO SATISFY THE
STOCKHOLDER VOTE REQUIREMENT AND NO ADDITIONAL VOTES WILL
CONSEQUENTLY BE NEEDED TO APPROVE THIS MATTER.
By order of the Board of Directors,
/s/ Xue Ran GAO
Xue Ran GAO
Chief Executive Officer and Director
July 29, 2020
AS CAPITAL, INC.
INFORMATION STATEMENT REGARDING
CORPORATE ACTIONS TAKEN BY WRITTEN CONSENT OF
OUR BOARD OF DIRECTORS AND HOLDERS OF
A MAJORITY OF OUR VOTING CAPITAL STOCK
IN LIEU OF SPECIAL MEETING
AS Capital, Inc. (“ASIN,” “the Company,” “we” or “us”) is
furnishing this information statement to you to provide a
description of actions taken by our Board of Directors and the
holder of a majority of our outstanding voting capital stock on
July 11, 2020, in accordance with the relevant sections of Nevada
Revised Statutes of the State of Nevada (the “NRS”).
This information statement is being mailed on or about July 31,
2020, to stockholders of record on July 11, 2020 (the “Record
Date”). The information statement is being delivered only to inform
you of the corporate actions described herein before such actions
take effect in accordance with Rule 14c-2 promulgated under the
Securities Exchange Act of 1934, as amended (the “Exchange Act”).
No action is requested or required on your part.
WE ARE NOT ASKING YOU FOR A PROXY AND YOU ARE REQUESTED NOT TO
SEND US A PROXY.
THIS IS NOT A NOTICE OF A MEETING OF STOCKHOLDERS AND NO
STOCKHOLDERS' MEETING WILL BE HELD TO CONSIDER ANY MATTER DESCRIBED
HEREIN.
PLEASE NOTE THAT THE HOLDERS OF A MAJORITY OF OUR OUTSTANDING
SHARES OF COMMON STOCK HAVE VOTED TO AUTHORIZE THE CORPORATE
ACTIONS. THE NUMBER OF VOTES RECEIVED IS SUFFICIENT TO SATISFY THE
STOCKHOLDER VOTE REQUIREMENT AND NO ADDITIONAL VOTES WILL
CONSEQUENTLY BE NEEDED TO APPROVE THESE MATTERS.
GENERAL DESCRIPTION OF CORPORATE ACTION
On July 11, 2020, the board of directors of AS Capital, Inc., a
Nevada corporation (“ASIN,” “the Company,” “we” or “us”), and
stockholders holding a majority of the voting rights of our common
stock approved by written consent in lieu of a special meeting the
taking of all steps necessary to effect the following actions
(collectively, the “Corporate Actions”):
|
1. |
Amend the Articles of Incorporation filed with
the Nevada Secretary of State (the “Articles of Incorporation”) to
increase the Company’s authorized capital stock from 110,000,000 to
510,000,000 shares of its capital stock, consisting of 500,000,000
shares of common stock, par value $0.0001, and 10,000,000 shares of
preferred stock, par value $0.0001; and |
|
2. |
Adopt
the Amended and Restated Bylaws of the Company. |
VOTING AND VOTE REQUIRED
Pursuant to ASIN’s Bylaws and the NRS, a vote by the holders of at
least a majority of ASIN’s outstanding capital stock is required to
effect the actions described herein. Each common stockholder is
entitled to one vote for each share of common stock held by such
stockholder. As of the Record Date, ASIN had 11,201,030 shares of
common stock issued and outstanding. The voting power representing
not less than 5,600,516 shares of common stock is required to pass
any stockholder resolutions. Pursuant to Section 78.320 of the NRS,
the following stockholder holding an aggregate of 8,581,063 shares
of common stock, or approximately 76.61% of the issued and
outstanding shares of our common stock on the Record Date (the
“Majority Stockholder”), delivered an executed written consent
dated July 11, 2020, authorizing the Corporate Actions.
Name |
|
Common Shares Beneficially Held |
|
|
Percentage of Issued and Outstanding |
|
Xue Ran GAO |
|
|
8,581,063 |
|
|
|
76.61% |
|
TOTAL |
|
|
8,581,063 |
|
|
|
76.61% |
|
NO APPRAISAL RIGHTS
Under the NRS, stockholders are not entitled to appraisal rights
with respect to the Corporate Actions, and we will not provide our
stockholders with such rights.
INTEREST OF CERTAIN PERSONS IN MATTERS TO BE ACTED UPON
Except in their capacity as stockholders, none of our officers,
directors or any of their respective affiliates has any interest in
the Corporate Actions.
CORPORATE ACTION NO. 1
INCREASE IN AUTHORIZED CAPITAL
On July 11, 2020, the Board and the Majority
Stockholder authorized, adopted and approved by written consent in
lieu of a special meeting an amendment to the Articles of
Incorporation to increase its authorized share capital from
110,000,000 to 510,000,000 shares of its common stock, consisting
of 500,000,000 shares of common stock, par value $0.0001, and
10,000,000 shares of preferred stock, par value $0.0001. The
proposed amendment to our Articles of Incorporation is
included in the Certificate of Amendment to the Articles of
Incorporation, which is attached hereto as Exhibit 1. The
general purpose and effect of this amendment to our Articles of
Incorporation is to increase our authorized share capital, which we
believe will enhance our ability to make acquisitions of operating
businesses and finance the development and operation of our
business.
Reasons For The Increase In Authorized Capital
Our current principal business is to achieve long-term growth
potential through a combination with a business rather than
immediate, short-term earnings. Based on proposed business
activities, we are a “blank check” company. Our principal business
objective for the next 12 months and beyond such time will be to
achieve long-term growth potential through a combination with a
business rather than immediate, short-term earnings. We are at all
times investigating potential business acquisition or combination
candidates, additional sources of financing, and other
opportunities which our Board believes will be in our best
interests and in the best interests of our stockholders. We are
currently in active discussions with and conducting in due
diligence on one or more potential business combination candidates
but have not entered into any binding agreements relating thereto.
Depending upon the outcome of our due diligence activities and
discussions, we hope to enter into binding acquisition or business
partnership agreements in the near future after the Effective
Date.
Our Board authorized and approved the proposed amendment to our
Articles of Incorporation to increase our authorized share capital
so that such shares will be available for issuance for acquisition,
combination and other general corporate purposes, such as financing
and acquisition activities, without the requirement of further
action by our stockholders. Potential uses of the additional
authorized shares may include, but are not limited to, public or
private offerings, conversions of convertible securities, issuance
of options pursuant to employee stock option plans, acquisition
transactions and other general corporate purposes. Increasing the
authorized number of shares of our common stock will give us
greater flexibility and will allow us to issue such shares, in most
cases, without the expense or delay of seeking stockholder
approval.
Except as set forth above, as of the date of this filing we do not
have any definitive plans, proposals or arrangements to issue any
of the newly available authorized shares of common stock for any
purpose or which may result in a change in control of the
Company.
Effect of the Increase in Authorized Capital; Anti-Takeover
Implications
The amendment to our Articles of Incorporation to increase our
authorized share capital will not have any immediate effect on the
rights of existing stockholders. However, our Board will have the
authority to issue shares of our Common Stock and Preferred Stock
without requiring future stockholder approval of such issuances,
except as may be required by applicable law or exchange
regulations. To the extent that additional shares of Common Stock
are issued in the future, such issuance will decrease the existing
stockholders' percentage equity ownership, dilute the earnings per
share and book value per share of outstanding shares of Common
Stock and, depending upon the price at which they are issued, could
be dilutive to the existing stockholders.
Although the increase in authorized capital is prompted by business
and financial considerations, stockholders nevertheless should be
aware that such increase could facilitate future efforts by our
management to deter or prevent a change in control of the Company.
By way of example, our management could issue additional shares to
dilute the stock ownership and the voting power of persons seeking
to obtain control of the Company or shares could be issued to
purchasers who would support the Board in opposing a takeover
proposal. In addition, the increase in authorized shares may have
the effect of delaying or discouraging a challenge for control or
make it less likely that such a challenge, if attempted, would be
successful, including challenges that are favored by a majority of
the stockholders or in which the stockholders might otherwise
receive a premium for their shares over then-current market prices
or benefit in some other manner. The Board and executive officers
of the Company have no knowledge of any current effort to obtain
control of the Company or to accumulate large amounts of Common
Stock.
Shortly after the Effective Date, the Board intends to acquire an
operating company. We may also conduct a private placement of our
securities to secure additional working capital for the Company.
Except as set forth above, the Board has no current plans to use
any of the additional shares of Common Stock that will become
available when the increase in authorized capital occurs to deter
or prevent a change of control of the Company.
CORPORATE ACTION NO. 2
ADOPTION OF AMENDED AND RESTATED BYLAWS
On July 11, 2020, the Board and the Majority Stockholder
authorized, adopted and approved by written consent in lieu of a
special meeting the Amended and Restated Bylaws of the Company (the
“Restated Bylaws”).
The Restated Bylaws contain new provisions that may have the effect
of delaying, deferring or discouraging another person from
acquiring control of the Company. These provisions are
designed to encourage persons seeking to acquire control of us to
first negotiate with our Board and to discourage certain types of
coercive takeover practices and inadequate takeover bids. Among
other things, the Restated Articles and the Restated Bylaws provide
that:
|
· |
A majority of the outstanding shares of the Corporation entitled to
vote, represented in person or any proxy, shall constitute a quorum
at a meeting of stockholders;
|
|
|
|
|
· |
Our
stockholders may not call special meetings of our stockholders
unless they hold in excess of 50% of the shares entitled to vote at
a meeting of stockholders. Stockholders requesting a
special meeting to act on any matter that may properly be
considered at a meeting of stockholders must submit a written
request to the secretary of the Corporation. Such meeting request
must contain all information required pursuant to the Restated
Bylaws, be sent to the secretary by registered mail, return receipt
requested, and be received by the secretary within 60 days after
the record date. The Restated Bylaws include special
provisions relating to the mechanics of calling and canceling
special meetings of the stockholders; |
|
· |
In
any annual meeting of our stockholders, stockholders may not act on
any matter not properly brought before the meeting. A
matter is considered to have been properly brought before a meeting
if the stockholder has given timely notice thereof in writing to
the secretary of the Corporation and such business is a proper
matter for action by the stockholders. To be timely, a
stockholder’s notice shall set forth all information required
pursuant to the Restated Bylaws and shall be delivered to the
secretary at the principal executive office of the Corporation not
earlier than the 150th day nor later than 5:00 p.m., Eastern Time,
on the 120th day prior to the first anniversary of the date of the
proxy statement for the preceding year’s annual meeting; provided,
however, that in the event that the date of the annual meeting is
advanced or delayed by more than 30 days from the first anniversary
of the date of the preceding year’s annual meeting, notice by the
stockholder to be timely, such notice must be so delivered not
earlier than the 150th day prior to the date of such annual meeting
and not later than 5:00 p.m., Eastern Time, on the later of the
120th day prior to the date of such annual meeting, as originally
convened, or the tenth day following the day on which public
announcement of the date of such meeting is first made. The public
announcement of a postponement or adjournment of an annual meeting
shall not commence a new time period for the giving of a
stockholder’s notice as described above. |
|
· |
Our stockholders may not nominate persons to our Board unless they
comply with certain nomination procedures. A stockholder
must deliver notice of its intent to nominate persons to be elected
to the Board to the secretary of the Company not earlier than the
150th day nor later than 5:00 p.m., Eastern Time,
on the 120th day prior to the first anniversary of
the date of the proxy statement for the preceding year’s annual
meeting; provided, however, that in the event that the date of the
annual meeting is advanced or delayed by more than 30 days from the
first anniversary of the date of the preceding year’s annual
meeting, notice by the stockholder to be timely, such notice must
be so delivered not earlier than the 150th day
prior to the date of such annual meeting and not later than 5:00
p.m., Eastern Time, on the later of the 120th day
prior to the date of such annual meeting, as originally convened,
or the tenth day following the day on which public announcement of
the date of such meeting is first made. The public announcement of
a postponement or adjournment of an annual meeting shall not
commence a new time period for the giving of a stockholder’s notice
as described above. Such stockholder’s notice must include all
information required pursuant to the Restated Bylaws, which shall
include information regarding (i) the stockholder, (ii) any
person acting in concert with such stockholder, (iii) any
beneficial owner of shares of stock of the Corporation owned of
record or beneficially by such stockholder (other than a
stockholder that is a depositary) and (iv) any person
that directly, or indirectly through one or more intermediaries,
controls, or is controlled by, or is under common control with,
such stockholder or any of the persons described in sections
(ii) and (iii) above.
Such notice shall contain, among other things, a written
undertaking certifying that such proposed nominee is not, and will
not become a party to, any agreement, arrangement or understanding
with any person or entity other than the Company in connection with
service or action as a director that has not been disclosed to the
Company.
|
|
· |
Our
directors have the power to adopt, amend or repeal our bylaws
without stockholders approval; |
|
· |
Our
stockholders may not cumulate votes in the election of directors;
and |
|
· |
We
will indemnify directors and officers against losses that they may
incur in investigations and legal proceedings resulting from their
services to us, which may include services in connection with
takeover defense measures and advance such
expenses on their behalf prior to final adjudication of whether
such directors and officers were entitled to
indemnification. |
In addition to the above-described changes, the following is a
description of certain other changes between the original Bylaws
and the Restated Bylaws, none of which, we believe, will have a
material impact on the Company’s stockholders:
|
· |
Under
the original Bylaws, proxies signed by stockholders are only valid
for 6 months unless a longer period is provided for in the proxy,
which period shall not to exceed 7 years. Under the Restated Bylaws
proxies signed by stockholders are only valid for 11 months unless
a longer period is provided for in the proxy. |
|
· |
Under
the original Bylaws, a special meeting of the directors may be
called by the President, Secretary, or two directors on seven (7)
days notice if delivered personally or by mail, telegram or
telephone. Under the Restated Bylaws, special meeting of the
directors may be called by or at the request of the Chief Executive
Officer, any two directors or the Chairman of the
Board. |
The Restated Bylaws, a copy of which is attached to this
Information Statement as Exhibit 2, will be effective on or
about the Effective Date.
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND
MANAGEMENT
The following table sets forth certain information with respect to
the beneficial ownership of our common stock, as of July 11, 2020,
for: (i) each of our named executive officers; (ii) each of our
directors; (iii) all of our current executive officers and
directors as a group; and (iv) each person, or group of affiliated
persons, known by us to be the beneficial owner of more than 5% of
our outstanding shares of common stock.
Beneficial ownership is determined in accordance with SEC rules and
generally includes voting or investment power with respect to
securities. For purposes of this table, a person or group of
persons is deemed to have “beneficial ownership” of any shares of
common stock that such person has the right to acquire within 60
days of July 11, 2020. For purposes of computing the percentage of
outstanding shares of our common stock held by each person or group
of persons named above, applicable percentage ownership is based on
11,201,030 shares of common stock outstanding as of July 11, 2020,
and any shares that such person or persons has the right to acquire
within 60 days of July 11, 2020, is deemed to be outstanding for
such person, but is not deemed to be outstanding for the purpose of
computing the percentage ownership of any other person. The
inclusion herein of any shares listed as beneficially owned does
not constitute an admission of beneficial ownership.
Except as indicated in footnotes to this table, we believe that the
stockholders named in this table will have sole voting and
investment power with respect to all shares of common stock shown
to be beneficially owned by them, based on information provided to
us by such stockholders. Unless otherwise indicated, the address
for each director and executive officer listed is: c/o AS Capital,
Inc. 3-11 Building 3, Beihuan East Road, Pinggu Town, Pinggu
District, Beijing, People's Republic of China.
Name of Beneficial Owner |
|
Amount and Nature of
Beneficial Ownership
|
|
|
Percent
of Class
|
|
|
|
|
|
|
|
|
Xue Ran GAO
(1) |
|
|
8,581,063 |
|
|
|
76.61% |
|
All executive officers and
directors as a group (one person) |
|
|
8,581,063 |
|
|
|
76.61% |
|
|
|
|
|
|
|
|
|
|
5% or Greater
Stockholders |
|
|
|
|
|
|
|
|
Zhang Yan Hua |
|
|
1,935,633 |
|
|
|
17.28% |
|
(1) |
Ms. GAO owns 964 shares of Series A Convertible
Preferred Stock, constituting 96.4% of the issued and outstanding
shares of the Series A Convertible Preferred Stock. |
CHANGE IN CONTROL
On June 4, 2019, AS Capital, Inc., a Nevada corporation (“we,”
“ASIN” or the “Company”), XRC, LLC, a Colorado limited liability
company (“XRC”) and Gao Xue Ran (“Purchaser”) entered into a Stock
Purchase Agreement (the “SPA”), pursuant to which Purchaser agreed
to purchase from XRC 11,000,000 shares of common stock of the
Company, par value $0.0001, and 964 shares of Series A Convertible
Preferred Stock Preferred Stock of the Company, par value $0.00001
(collectively, the “Shares”), for aggregate consideration of Four
Hundred and Ten Thousand Dollars ($410,000) in accordance with the
terms and conditions of the SPA. XRC is the controlling shareholder
of the Company. On June 13, 2019, and in anticipation of the sales
transaction with Ms. Gao, the Company assigned its line of credit
and the current balance due thereunder, including all outstanding
principal and accrued interest, to XRC in consideration of
10,000,000 shares of common stock of the Company. At the time of
the transfer, $48,595 was due under the line of credit. At the same
time XRC converted its 1,000,000 shares of Series C Convertible
Preferred Stock into 1,000,000 shares of common stock. Chris Lotito
is the managing member of XRC.
The acquisition of the Shares consummated on July 18, 2019, and the
Shares were ultimately purchased by the following three individuals
using their own personal funds:
Name |
No. of Shares |
Percentage of Issued and Outstanding |
Consideration Paid |
Gao
Xue Ran |
8,581,063 of Common Stock;
964 shares of Series A Preferred Stock
|
76.61% |
$319,840 |
Zhang
Yan Hua |
1,935,633 of Common Stock |
17.28% |
$72,146 |
Cheung Kwok Chiu Kris |
483,304 of Common Stock |
4.31% |
$18,014 |
Immediately after the acquisition, Ms. Gao held a controlling
interest in the Company and could unilaterally determine the
election of the Board and other substantive matters requiring
approval of the Company’s stockholders.
Upon the consummation of the sale of the Shares, Chris Lotito, our
Chief Executive Officer and sole director, and John Karatzaferis,
our President, resigned from all of their positions with the
Company, effective July 18, 2019. Their resignations were not due
to any dispute or disagreement with the Company on any matter
relating to the Company's operations, policies or practices.
Concurrently with such resignations, Gao Xue Ran was appointed to
serve as the Chief Executive Officer, Chief Financial Officer,
President, Secretary and sole Director of the Company, until the
next annual meeting of stockholders of the Company and until such
director’s successor is elected and qualified or until such
director’s earlier death, resignation or removal. None of the
directors or executive officers has a direct family relationship
with any of the Company’s directors or executive officers, or any
person nominated or chosen by the Company to become a director or
executive officer. Ms. Gao will serve in her positions without
compensation.
FORWARD-LOOKING STATEMENTS
This Information Statement may contain certain “forward-looking”
statements (as that term is defined in the Private Securities
Litigation Reform Act of 1995 or by the U.S. Securities and
Exchange Commission in its rules, regulations and releases)
representing our expectations or beliefs regarding our
company. These forward- looking statements include, but
are not limited to, statements regarding our business, anticipated
financial or operational results and objectives. For
this purpose, any statements contained herein that are not
statements of historical fact may be deemed to be forward-looking
statements. Without limiting the generality of the foregoing, words
such as “may,” “will,” “expect,” “believe,” “anticipate,” “intend,”
“could,” “estimate,” “might,” or “continue” or the negative or
other variations thereof or comparable terminology are intended to
identify forward-looking statements. These statements, by their
nature, involve substantial risks and uncertainties, certain of
which are beyond our control, and actual results may differ
materially depending on a variety of important factors, including
factors discussed in this and other filings of ours with the
Securities and Exchange Commission.
GENERAL INFORMATION
ASIN will pay all costs associated with the distribution of this
Information Statement, including the costs of printing and mailing.
ASIN will reimburse brokerage firms and other custodians, nominees
and fiduciaries for reasonable expenses incurred by them in sending
this Information Statement to the beneficial owners of ASIN’s
common stock.
ASIN will deliver only one Information Statement to multiple
security holders sharing an address unless ASIN has received
contrary instructions from one or more of the security holders.
Upon written or oral request, ASIN will promptly deliver a separate
copy of this Information Statement and any future annual reports
and information statements to any security holder at a shared
address to which a single copy of this Information Statement was
delivered, or deliver a single copy of this Information Statement
and any future annual reports and information statements to any
security holder or holders sharing an address to which multiple
copies are now delivered. You should direct any such
requests to the following address: AS Capital, Inc. Room 1206, 12th
Floor, 301, 3-17 F, Building 5, Block 1, Hangfeng Road, Fengtai
District, Beijing. The Secretary may also be reached by
telephone at +86 137 168 55155.
ADDITIONAL AND AVAILABLE INFORMATION
ASIN is subject to the informational filing requirements of the
Exchange Act and, in accordance therewith, is required to file
periodic reports, proxy statements and other information with the
SEC relating to its business, financial condition and other
matters. Such reports, proxy statements and other information can
be inspected and copied at the public reference facility maintained
by the SEC at 100 F Street, N.E., Washington, D.C. 20549.
Information regarding the public reference facilities may be
obtained from the SEC by telephoning 1-800-SEC-0330. Our filings
are also available to the public on the SEC’s website
(www.sec.gov).
Dated: July
29, 2020 |
By order of the Board of Directors
/s/ Xue Ran GAO
By: Xue Ran GAO
Chief Executive Officer, Chief Financial Officer and Secretary
|
Exhibit 1: Certificate of Amendment to Articles of
Incorporation of the Company*
Exhibit 2: Amended and Restated Bylaws of the
Company*
*Filed herewith.
AS Capital (PK) (USOTC:ASIN)
Historical Stock Chart
From Dec 2020 to Jan 2021
AS Capital (PK) (USOTC:ASIN)
Historical Stock Chart
From Jan 2020 to Jan 2021